Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Kotzsch,
J.Nickel,
A.Seher,
W.Sebald,
and
T.D.Müller
(2009).
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
|
| |
EMBO J, 28,
937-947.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Tesseur,
H.Zhang,
W.Brecht,
J.Corn,
J.S.Gong,
K.Yanagisawa,
M.Michikawa,
K.Weisgraber,
Y.Huang,
and
T.Wyss-Coray
(2009).
Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3.
|
| |
J Neurochem, 110,
1254-1262.
|
 |
|
|
|
|
 |
I.Torregroza,
T.Evans,
and
B.C.Das
(2009).
A forward chemical screen using zebrafish embryos with novel 2-substituted 2H-chromene derivatives.
|
| |
Chem Biol Drug Des, 73,
339-345.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J, 28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.P.Holbourn,
B.Perbal,
and
K.Ravi Acharya
(2009).
Proteins on the catwalk: modelling the structural domains of the CCN family of proteins.
|
| |
J Cell Commun Signal, 3,
25-41.
|
 |
|
|
|
|
 |
A.Galat,
G.Gross,
P.Drevet,
A.Sato,
and
A.Ménez
(2008).
Conserved structural determinants in three-fingered protein domains.
|
| |
FEBS J, 275,
3207-3225.
|
 |
|
|
|
|
 |
C.Grütter,
T.Wilkinson,
R.Turner,
S.Podichetty,
D.Finch,
M.McCourt,
S.Loning,
L.Jermutus,
and
M.G.Grütter
(2008).
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
|
| |
Proc Natl Acad Sci U S A, 105,
20251-20256.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.P.Holbourn,
K.R.Acharya,
and
B.Perbal
(2008).
The CCN family of proteins: structure-function relationships.
|
| |
Trends Biochem Sci, 33,
461-473.
|
 |
|
|
|
|
 |
Y.Glinka,
and
G.J.Prud'homme
(2008).
Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
|
| |
J Leukoc Biol, 84,
302-310.
|
 |
|
|
|
|
 |
Y.Makanji,
K.L.Walton,
M.C.Wilce,
K.L.Chan,
D.M.Robertson,
and
C.A.Harrison
(2008).
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.
|
| |
J Biol Chem, 283,
16743-16751.
|
 |
|
|
|
|
 |
D.Weber,
A.Kotzsch,
J.Nickel,
S.Harth,
A.Seher,
U.Mueller,
W.Sebald,
and
T.D.Mueller
(2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
|
| |
BMC Struct Biol, 7,
6.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.M.Smallwood,
J.Williams,
Q.Xu,
D.J.Leahy,
and
J.Nathans
(2007).
Mutational analysis of Norrin-Frizzled4 recognition.
|
| |
J Biol Chem, 282,
4057-4068.
|
 |
|
|
|
|
 |
T.Shimanuki,
T.Hara,
T.Furuya,
T.Imamura,
and
K.Miyazono
(2007).
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
|
| |
Oncogene, 26,
3311-3320.
|
 |
|
|
|
|
 |
A.E.Harrington,
S.A.Morris-Triggs,
B.T.Ruotolo,
C.V.Robinson,
S.Ohnuma,
and
M.Hyvönen
(2006).
Structural basis for the inhibition of activin signalling by follistatin.
|
| |
EMBO J, 25,
1035-1045.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Wong,
S.N.Albright,
and
M.F.Wolfner
(2006).
Evidence for structural constraint on ovulin, a rapidly evolving Drosophila melanogaster seminal protein.
|
| |
Proc Natl Acad Sci U S A, 103,
18644-18649.
|
 |
|
|
|
|
 |
C.Sieber,
F.Plöger,
R.Schwappacher,
R.Bechtold,
M.Hanke,
S.Kawai,
Y.Muraki,
M.Katsuura,
M.Kimura,
M.M.Rechtman,
Y.I.Henis,
J.Pohl,
and
P.Knaus
(2006).
Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity.
|
| |
Biol Chem, 387,
451-460.
|
 |
|
|
|
|
 |
G.Liu,
W.Ding,
J.Neiman,
and
K.M.Mulder
(2006).
Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion.
|
| |
J Biol Chem, 281,
29479-29490.
|
 |
|
|
|
|
 |
G.P.Allendorph,
W.W.Vale,
and
S.Choe
(2006).
Structure of the ternary signaling complex of a TGF-beta superfamily member.
|
| |
Proc Natl Acad Sci U S A, 103,
7643-7648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Gao,
and
A.Laughon
(2006).
Decapentaplegic-responsive silencers contain overlapping mad-binding sites.
|
| |
J Biol Chem, 281,
25781-25790.
|
 |
|
|
|
|
 |
A.J.Gore,
D.P.Philips,
W.L.Miller,
and
D.J.Bernard
(2005).
Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes.
|
| |
Reprod Biol Endocrinol, 3,
73.
|
 |
|
|
|
|
 |
F.S.Cheah,
E.W.Jabs,
and
S.S.Chong
(2005).
Genomic, cDNA, and embryonic expression analysis of zebrafish transforming growth factor beta 3 (tgfbeta3).
|
| |
Dev Dyn, 232,
1021-1030.
|
 |
|
|
|
|
 |
G.Valdimarsdottir,
and
C.Mummery
(2005).
Functions of the TGFbeta superfamily in human embryonic stem cells.
|
| |
APMIS, 113,
773-789.
|
 |
|
|
|
|
 |
H.H.Keah,
and
M.T.Hearn
(2005).
A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
|
| |
J Mol Recognit, 18,
385-403.
|
 |
|
|
|
|
 |
P.Llinas,
M.H.Le Du,
H.Gårdsvoll,
K.Danø,
M.Ploug,
B.Gilquin,
E.A.Stura,
and
A.Ménez
(2005).
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.
|
| |
EMBO J, 24,
1655-1663.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.W.Cook,
T.B.Thompson,
S.P.Kurup,
T.S.Jardetzky,
and
T.K.Woodruff
(2005).
Structural basis for a functional antagonist in the transforming growth factor beta superfamily.
|
| |
J Biol Chem, 280,
40177-40186.
|
 |
|
|
|
|
 |
X.H.Feng,
and
R.Derynck
(2005).
Specificity and versatility in tgf-beta signaling through Smads.
|
| |
Annu Rev Cell Dev Biol, 21,
659-693.
|
 |
|
|
|
|
 |
E.del Re,
J.L.Babitt,
A.Pirani,
A.L.Schneyer,
and
H.Y.Lin
(2004).
In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
|
| |
J Biol Chem, 279,
22765-22772.
|
 |
|
|
|
|
 |
E.del Re,
Y.Sidis,
D.A.Fabrizio,
H.Y.Lin,
and
A.Schneyer
(2004).
Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
|
| |
J Biol Chem, 279,
53126-53135.
|
 |
|
|
|
|
 |
G.De Crescenzo,
P.L.Pham,
Y.Durocher,
H.Chao,
and
M.D.O'Connor-McCourt
(2004).
Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization.
|
| |
J Biol Chem, 279,
26013-26018.
|
 |
|
|
|
|
 |
S.Keller,
J.Nickel,
J.L.Zhang,
W.Sebald,
and
T.D.Mueller
(2004).
Molecular recognition of BMP-2 and BMP receptor IA.
|
| |
Nat Struct Mol Biol, 11,
481-488.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.M.Leppänen,
M.M.Bespalov,
P.Runeberg-Roos,
U.Puurand,
A.Merits,
M.Saarma,
and
A.Goldman
(2004).
The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation.
|
| |
EMBO J, 23,
1452-1462.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Sebald,
J.Nickel,
J.L.Zhang,
and
T.D.Mueller
(2004).
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
|
| |
Biol Chem, 385,
697-710.
|
 |
|
|
|
|
 |
D.G.Winkler,
M.K.Sutherland,
J.C.Geoghegan,
C.Yu,
T.Hayes,
J.E.Skonier,
D.Shpektor,
M.Jonas,
B.R.Kovacevich,
K.Staehling-Hampton,
M.Appleby,
M.E.Brunkow,
and
J.A.Latham
(2003).
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
|
| |
EMBO J, 22,
6267-6276.
|
 |
|
|
|
|
 |
K.Miyazono,
H.Suzuki,
and
T.Imamura
(2003).
Regulation of TGF-beta signaling and its roles in progression of tumors.
|
| |
Cancer Sci, 94,
230-234.
|
 |
|
|
|
|
 |
T.B.Thompson,
T.K.Woodruff,
and
T.S.Jardetzky
(2003).
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
|
| |
EMBO J, 22,
1555-1566.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Y.Qin,
S.S.Lam,
J.J.Correia,
and
K.Lin
(2002).
Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control.
|
| |
Genes Dev, 16,
1950-1963.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.V.Bocharov,
D.M.Korzhnev,
M.J.Blommers,
T.Arvinte,
V.Y.Orekhov,
M.Billeter,
and
A.S.Arseniev
(2002).
Dynamics-modulated biological activity of transforming growth factor beta3.
|
| |
J Biol Chem, 277,
46273-46279.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|